Autologous
Uses the patient's own skin cells.
02 — Surgical Treatment
MyCell Cell Suspension Transplantation
Autologous Melanocyte Cell Suspension Therapy
MyCell cell suspension transplantation is an autologous surgical approach that prepares pigment-producing cells from the patient's own skin and applies them to selected depigmented areas to support gradual pigment restoration.
Treatment Process
01
Donor Skin Collection
A small sample of healthy skin is collected from the patient.
02
Tissue Processing
The donor skin is carefully processed to isolate pigment-producing cells.
03
Cell Suspension Preparation
The isolated cells are prepared into a melanocyte-rich cell suspension.
04
Targeted Transplantation
The cell suspension is precisely applied to the depigmented area.
05
Repigmentation
The transplanted cells support melanocyte regeneration and gradual pigment restoration.
Key Features
Cell Suspension
Delivers melanocyte-rich cells directly to the treatment area.
Targeted
Focuses treatment on localized depigmented skin.
Repigmentation
Supports the restoration of natural skin pigmentation.
Clinical Consideration
MyCell cell suspension transplantation may be considered for selected patients with stable vitiligo. Suitability, donor site planning, and post-procedure care should be determined by a qualified physician.